Glyphosate targets FYN to regulate glycolysis and promote glioblastoma proliferation: A network toxicology study

Anquan Ma1, Ziqing Yang1, Qixuan He1

  • 1Department of Prosthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneration & Shandong Provincial Clinical Research Center for Oral Diseases, Jinan 250012, China.

Insights

Environmental glyphosate exposure is linked to glioblastoma (GBM). This study identifies FYN kinase as the key target, revealing a new strategy for treating GBM by targeting FYN or its related pathways.

Area of Science:

  • Oncology
  • Toxicology
  • Molecular Biology

Background:

  • Environmental glyphosate exposure is a suspected risk factor for glioblastoma (GBM).
  • The precise molecular mechanisms linking glyphosate to GBM remain largely unknown.
  • Understanding these links is crucial for developing effective cancer prevention and treatment strategies.

Purpose of the Study:

  • To identify the molecular target of glyphosate relevant to glioblastoma.
  • To elucidate the signaling pathways and cellular processes affected by glyphosate in GBM.
  • To explore FYN kinase as a therapeutic target for glyphosate-induced GBM.

Main Methods:

  • Network-toxicology and Mendelian randomization screens to identify glyphosate targets.
  • Molecular-dynamics simulations, SPR, and pull-down assays to confirm FYN binding.
  • Multi-omics profiling, cell-based assays (U87), and orthotopic mouse models to assess FYN's role in GBM.
  • Exosome analysis to investigate immunometabolic effects.

Main Results:

  • FYN (a Src-family kinase) was identified as the principal high-affinity glyphosate target.
  • Glyphosate up-regulated FYN in GBM cells, activating PI3K-AKT-mTOR signaling and promoting tumor growth, migration, and invasion.
  • FYN knockdown reversed glyphosate-induced effects and suppressed tumor growth in vivo.
  • Targeting FYN modulated tumor glycolysis and reprogrammed the tumor immune microenvironment via exosomes.

Conclusions:

  • FYN kinase is the mechanistic link between glyphosate exposure and glioblastoma development.
  • Targeting FYN, directly or through exosome-mediated delivery, offers a promising therapeutic strategy for glyphosate-associated GBM.
  • This research uncovers a novel immunometabolism axis in GBM driven by FYN signaling.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.0K